Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.

Dengue fever is a common tropical infection. This acute febrile illness can be a deadly infection in cases of severe manifestation, causing dengue hemorrhagic shock. In this brief article ...

"A safe and effective dengue virus vaccine is clearly the long-term solution, but more immediate strategies are urgently needed to combat the current dengue problem." There is reason to be ...

Dengue fever is a viral illness spread through mosquito bites. While cases can be asymptomatic, many people experience high fever and painful body aches. Second infections are often more severe ...

Brazilian health authorities have expressed concern following the reappearance of the dengue virus serotype 3, particularly in the states of São Paulo, Minas Gerais, Amapá, and Paraná since the ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.